Comparative Efficacy and Safety of Finerenone, Eplerenone, and Spironolactone on Cardiorenal Outcomes in Type 2 Diabetes with Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis. OAIJMR. 2025;6(1):1-20. doi:10.37275/oaijmr.v6i1.819